US Patent 7405289 Pancreatic islet transcription factor and uses thereof
Patent 7405289 was granted and assigned to Metabolex on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Anthony C. Schweitzer0
Jeffrey D. Johnson0
John E. Blume0
John F. Palma0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+134 characters)
Article
Patent abstract
The present invention provides a pancreatic islet transcription factor and methods of treating and diagnosing diabetes.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07405289 Pancreatic islet transcription factor and uses thereof US Patent 7405289 Pancreatic islet transcription factor and uses thereof
Infobox
Patent Number
074052890
Patent Number
74052890
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074052890
Date of Patent
July 29, 2008
0Patent Application Number
105335930
Date Filed
November 13, 2003
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07405289 Pancreatic islet transcription factor and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07405289
Date of patent
July 29, 2008
Patent application number
10533593
Date Filed
November 13, 2003
Patent primary examiner
Find more entities like US Patent 7405289 Pancreatic islet transcription factor and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.